AstraZeneca To Buy Gracell For Up To $1.2 Bln

(RTTNews) - Biopharmaceutical major AstraZeneca PLC (AZN), announced on Tuesday that it has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (GRCL) for up to $1.2 billion in an all-cash transaction. https://www.nasdaq.com/articles/astrazeneca-to-buy-gracell-for-up-to-$1.2-bln